What stage does Parkwalk Advisors invest at?

Parkwalk Advisors invests at the Seed, Series A, Series B, Series C, Growth stages.

Where is Parkwalk Advisors located?

Parkwalk Advisors is headquartered in London, GB.

Does Parkwalk Advisors lead rounds?

Parkwalk Advisors typically participates in rounds rather than leading them.

Parkwalk Advisors

Venture capital

London · Seed–Growth · 30 people tracked

Also known as Park Walk Advisors Ltd

★ Follow + Add to CRM ⤳ Find an introduction

✨ Fox Verdict

Investment thesis

Parkwalk invests in deeptech spinouts emerging from UK universities, aiming to convert pioneering academic research into commercially successful businesses. It bridges the funding gap between early academic discovery and later-stage venture capital, investing across the spinout lifecycle from seed to scale. As a leading EIS fund manager, Parkwalk offers investors tax-efficient opportunities while providing spinouts with funding, expertise, and networks. As part of IP Group plc, it supports companies from start-up to scale-up across core sectors including AI, quantum computing, hardware, cleantech, digital health, and life sciences, positioning itself as the UK's most active investor in university spinouts.

Invests inAI & Machine Learning Biotech Cleantech Climate Tech Deep Tech Digital Health Hardware Healthtech IoT Medical Devices Quantum Computing SaaSLondonUnited Kingdom

Source: firm website, verified Aug 3, 2026.

Stage

Seed–Growth

London, GB

Leads rounds

Follows

Instruments

Equity

Founded

2009

AUM

$635M

Tracked investments

Team · 30 people

from the firm's website & public directories

Alastair Kilgour· Founder· Londonin

a•••@parkwalkadvisors.comreveal

Moray Wright· CEO· London, England, United Kingdomin 𝕏

Moray Wright is CEO of Parkwalk Advisors, a firm that manages several Enterprise Investment Scheme (EIS) funds. He has noted that the firm is seeing more savers use their pension lump sums to invest in companies through its funds as a financial planning strategy.

m•••@parkwalkadvisors.comreveal

John Pearson· Chief Investment Officer· Londonin

Joined Parkwalk in 2018 and was appointed CIO in 2024. Previously a partner at Adelphi Capital; has led exits to Microsoft and Apple and sits on several portfolio boards.

j•••@parkwalkadvisors.comreveal

Anne Dobrée· Investment Director· Greater Cambridge Areain

Joined Parkwalk in 2024 with experience supporting university spinouts since 2001 at Imperial College and Cambridge. Formerly led Cambridge's Seed Funds team and established the Founders accelerator.

Alun Williams· Investment Director· Londonin 𝕏

Joined Parkwalk in 2011 after 20 years managing debt capital markets at NatWest Markets and Royal Bank of Canada. Sits on the boards of several portfolio companies including Oxford spinouts Oxford Flow, Mind Foundry and Proxisense.

a•••@parkwalkadvisors.comreveal

Karolina Zapadka· Senior Investment Manager· Cambridge, United Kingdomin

k•••@parkwalkadvisors.comreveal

Martin Glen· Investment Director· London Area, United Kingdomin

A former hedge fund manager of 15 years and extel-rated analyst covering chemicals and pharma. Sits on the boards of Cytora and Psyomics; holds a BA in Chemistry from Oxford.

m•••@parkwalkadvisors.comreveal

Neil Cameron· Investment Director· Londonin

Investment Director responsible for Parkwalk's quantum computing investments, with directorships including Symetrica and Diffblue. Previously a Worldwide Consulting Partner at Arthur Andersen and a founder investor in Caffe Nero.

n•••@parkwalkadvisors.comreveal

Amy Virdee· Legal Counsel· Greater Cambridge Areain

Joined Parkwalk as Legal Counsel in 2022, previously an Emerging Companies associate at Taylor Vinters advising startups and investors. Holds an LLB from the University of East Anglia.

Chloe Woodacre· Head of Investor Relations· Greater London, England, United Kingdomin

Leads Parkwalk's Investor Relations team, having joined in 2015. Previously a technology analyst; holds a BSc from the University of Southampton.

Danielle Acuy· Senior Business & Data Analyst

Joined Parkwalk in 2026 supporting the investment team with portfolio analysis and data-driven insights. Previously worked in investor relations and investment analysis in the UK and Brazil.

David Townsend· Managing Director, IP Capital

Joined IP Group's Global Capital team in June 2025 with extensive institutional sales experience across EMEA at firms including Value Partners Group, First Eagle and Martin Currie.

George Van Horn· Vice President, IP Capital

Vice President within IP Capital, IP Group's fund management and capital raising team, since joining as a graduate analyst in 2018. Supports corporate finance advisory across deeptech and therapeutics.

Georgia Docker· Senior Investor Relations Associate· Bromley, England, United Kingdomin

Joined the Investor Relations team in March 2020, supporting client onboarding and compliance checks. Holds a BA in Economics from the University of Leicester.

Gordon Lawson· Non-Executive Chairman

Has 30 years of City experience, including senior roles at Salomon/Citigroup and founding hedge fund Pendragon Capital. Advises several hedge funds and sits on various advisory boards.

Greg Smith· Director, IP Group CEO

Chief Executive Officer of IP Group since October 2021, previously its CFO. Has over 20 years in financial services and qualified as an accountant at KPMG.

Harriet Doherty· Director of Sales and Marketing· United Kingdomin

Leads Parkwalk's marcomms strategy and fundraising for its EIS funds. Previously Director of Sales and Marketing at Kin Capital and worked at Calculus Capital.

Helen Redmond· Chief Risk Officer

Leads IP Group's operational risk and regulatory compliance, holding Compliance Officer and MLRO regulatory roles. Qualified as a Chartered Accountant at PwC in Dublin.

Joyce Xie· Managing Director, Global Capital, Institutional Fundraising

Joined IP Group in 2016 and leads its third-party fund management capital market team. Founder of IP Group Greater China; previously worked in M&A advisory at HSBC.

Lucy Allen· Marketing Manager· London, England, United Kingdomin

Joined Parkwalk in 2024, previously Marketing Manager at Edison Group. Holds a BA from the University of Exeter and a CIM Level 6 diploma.

Olivia Smith· Investor Relations Manager

Investor Relations Manager supporting client onboarding and the EIS process, having joined in 2017. Previously worked in the oil and gas industry.

Samiksha Rai· Investor Relations Assistant· London, England, United Kingdomin

Investor Relations Assistant since 2023, supporting investor onboarding and client support. Graduated with First Class Honours from the University of Hertfordshire.

Will Crompton· General Counsel

Parkwalk's General Counsel with over 10 years in venture capital, M&A and corporate law across deeptech, cleantech and healthcare. Previously Senior Legal Counsel at IP Group.

Wisdom Yemi· Investment Analyst· United Kingdomin

Joined the investment team as an analyst in March 2023, working on statistical analysis and relationship databases. Holds a first class honours degree in Mathematics from Coventry University.

Enrico D'Angelo· CFO

e•••@parkwalkadvisors.comreveal

Kathy Samii· Chief Operating Officer

Joined Parkwalk in 2016 after COO, CFO and compliance roles at a large event-driven hedge fund. Previously worked at Citigroup and Merrill Lynch.

k•••@parkwalkadvisors.comreveal

Susie Harris· Director of Business Development· London, England, United Kingdomin

Leads Parkwalk's fundraising strategy and strategic partnerships. Previously Head of Internal Business Development at Puma Investments and sits on EISA committees.

s•••@parkwalkadvisors.comreveal

Wisdom Yemi-Makanjuola· Investment Analyst

w•••@parkwalkadvisors.comreveal

Emilie Syed· Investor· Oxford, England, United Kingdomin

Has nearly a decade of experience building and investing in university spinouts, serving on the Investment Committee at Parkwalk Advisors and previously at Oxford University Innovation. A former research scientist, she holds a PhD in Neuroscience and an MBA from Warwick Business School.

Ian Broadhurst· United Kingdomin

What they invest in

from 8 of 21 portfolio companies

AI & Machine Learning ×3Cleantech ×3Healthtech ×3Medical Devices ×3Advanced Manufacturing ×2Biotech ×1Deep Tech ×1Digital Health ×1

HQs:United Kingdom×2

Investments · 21 tracked

founders shown can be your intro path

1715 Labs

Data labelling platform for AI

52 North Health

Finger prick blood test for chemo patients

52north Seed52north.healthin

8power8power.comin 𝕏

8power builds 'Fit & Forget' wireless sensors that provide real-time condition monitoring, data and analytics for industrial machinery such as pumps, motors and gearboxes, allowing clients to track remote asset performance and plan maintenance.

Advanced ManufacturingAI & Machine LearningCleantechEnterprise SoftwareHardwareIoTCambridge, GB

Paul Egan(CEO)Glen Clark(CFO)Richard Green(Chairman)

ACAL Energy

Accelercommaccelercomm.com

Adsilicoadsilico.uk

adsilico builds generative AI technology that creates diverse virtual patient populations—digital models of human anatomy, physiology, and pathology—to run in silico trials that assess medical device safety and performance before human testing.

AI & Machine LearningHealthtechMedical Devices

Sheena MacphersonDr Nishant RavikumarDr Zeike TaylorProf Alejandro Frangi

Albus Healthalbushealth.comin 𝕏

Albus Health develops clinically validated monitoring technology that tracks respiratory metrics, heart rate, and cough frequency to support clinical studies.

BiotechDigital HealthHealthtechMedical Devices

Dr Richard Russell(Clinical Lead)Prof Ian Pavord(Clinical Lead)Prof Maarten De Vos(Head of R&D)Carmine Clemente(RF Technology Advisor)

Animal Dynamics

Bio-inspired vehicles; spinout from University of Oxford's Department of Zoology

Aqdotaqdot.com

Aqdot is a supramolecular chemistry (chem-tech) company that develops proprietary AqFresh air quality and odour/VOC-elimination technology based on encapsulation.

CleantechDeep TechNew Materials

Dr Jing Zhang(Chief Executive Officer & Co-founder)Dr Roger Coulston(Chief Technical Officer & Co-founder)Hugh Rathbone(Chief Commercial Officer)Alex Anikeeva(Chief Financial Officer)Tim Wright(Chairman)

Arkivumarkivum.comin 𝕏

Arvia

Industrial water treatment company

Arviatechnologyarviatechnology.comin 𝕏

Arvia Technology designs and manufactures wastewater treatment systems that remove persistent organic chemicals from industrial effluent across pharmaceutical, chemical, agricultural, and aquaculture sectors.

Advanced ManufacturingCleantech

Audiotelligence

Disruptive hearing/audio clarity technology start-up

Azul Opticsazuloptics.comin 𝕏

Azulo Optics develops diagnostic devices that measure blue light damage to the retina, helping eye care practices screen patients for macular degeneration risk and boost revenue through preventive vision care services.

HealthtechMedical Devices

Barocalbarocal.com

Clean alternative to fluid refrigerants using barocaloric effect

BibliUbibliu.comin 𝕏

BibliU is a digital learning platform that partners with publishers to provide students affordable, instant access to course content, and offers institutions workflow automation to reduce administrative burden.

EdTechSaaS

Dave Sherwood(Co-Founder & CEO)

Cytoracytora.comin 𝕏acquired by Applied Systems

Cytora is a risk digitization and automation platform for commercial insurance that uses AI to help brokers, insurers, and reinsurers receive, process, and make decisions on risk submissions.

AI & Machine LearningInsurTech

Moa Technology

Portfolio company that raised a £22.2m Series C funding round

Pet Medixpetmedix.com

Novel antibody-based therapeutics platform for animal health.

Yasayasa.cominacquired by Mercedes Benz

Acquired by Mercedes-Benz in 2021

Exits · 2

IPOs and acquisitions across the tracked portfolio

Cytoraacq. by Applied SystemsYasaacq. by Mercedes Benz

Principals & officers · per Companies House

what is this? ⓘ

Gordon William Lawson

Director · British · since 2015

John Richard Pearson

Director · British · since 2024

Katayoun Samii

Director · British · since 2021

Gregory Simon Smith

Director · British · since 2022

Douglas Moray Wright

Director · British · since 2009

Ownership & control

Ip Group Plc — 75–100% of shares

Frequently asked questions

What stage does Parkwalk Advisors invest at?: Parkwalk Advisors invests at the Seed, Series A, Series B, Series C, Growth stages.
What sectors does Parkwalk Advisors focus on?: Parkwalk Advisors focuses on AI & Machine Learning, Biotech, Cleantech, Climate Tech, Deep Tech, Digital Health, Hardware, Healthtech, IoT, Medical Devices, Quantum Computing, SaaS.
Where is Parkwalk Advisors located?: Parkwalk Advisors is headquartered in London, GB.
Does Parkwalk Advisors lead rounds?: Parkwalk Advisors typically participates in rounds rather than leading them.

Images

Co-investors · 16

Oxford Science Enterprises

Oxford Science Enterprises builds and funds companies based on cutting-edge research through a partnership with the University of Oxford, turning scientific breakthroughs into ventures.

Both backed · 3

BibliU YasaMoa Technology

$63.5K – $31.8M

Cambridge Innovation Capital

Cambridge Innovation Capital (CIC) is a UK-based venture capital firm backing entrepreneurs in life sciences and deep tech, leveraging its position in the Cambridge science and technology ecosystem.

Both backed · 2

Cytora Pet Medix

$127K – $12.7M

Digitalis Ventures

Digitalis Ventures invests in solutions to unmet needs in biomedicine and health, backing biotechnology and technology-enabled companies across human health and animal health.

Both backed · 1

Pet Medix

$100K – $10M

Future Planet Capital

Future Planet Capital is a UK-founded, impact-led venture capital firm that invests globally in high-growth companies emerging from top universities and centres of innovation.

Both backed · 1

52north Seed

Amadeus Capital Partners

Amadeus Capital Partners is a deep tech investor backing companies across the themes of Intelligence, Human potential, and the Planet.

$50K – $12.7M

LocalGlobe

LocalGlobe is part of a multi-generational Phoenix Court platform that backs companies from pre-seed through public markets, founded by the Klein family who are considered founders of European seed investing with multi-decade relationships across the European tech ecosystem. The fund operates from a physical founder village at Phoenix Court in London and focuses on backing unconventional entrepreneurs in specific geographic neighbourhoods, having been among the earliest institutional backers of European outliers like Wise, Zoopla, and Citymapper.

Playground Global

Playground Global is a venture firm focused on deep technology, working alongside founders as engineers, operators, and scientists to help commercialize breakthrough technology into scalable businesses.

$1M – $20M

HTGF

HTGF is a venture capital firm that invests in technology companies and new business models.

$1.1M

AlbionVC

AlbionVC is an early-stage venture capital firm backing European founders, providing both capital and operational expertise across deeptech, health, finance, and intelligence sectors.

Business Growth Fund

BGF provides minority growth capital and support to entrepreneurial small and medium-sized businesses across the UK and Ireland, from university spinouts to established brands.

$3.8M – $38M

ACF Investors

ACF Investors is a £100M UK venture capital fund that backs entrepreneurs across most sectors, co-investing alongside sector-focused angel investors.

$125K – $1.3M

Astellas Venture Management LLC

Astellas Venture Management (AVM) is the wholly-owned corporate venture arm of Astellas, providing equity investments to private, early-stage biotechnology companies developing therapeutic programs and platform technologies for drug discovery.

$200K – $5M

▶4 more co-investors

ePlanet Capital Bioqube Ventures Sana Capital Modi Ventures

Firms observed investing alongside Parkwalk Advisors, from public investor directories. Shared companies are the overlap with Parkwalk Advisors's recorded portfolio.

Similar investors

BDC Fund Investments (Fund-of-Funds)

BDC Capital's venture capital arm makes fund investments, and is a limited partner in Amplitude Ventures' Fund I. This page profiles Amplitude Ventures, a portfolio fund.

DCVC (Data Collective)

DCVC (Data Collective) is a venture capital firm that backs founders building companies which apply technology to major challenges across areas such as energy, biotech, agriculture, and machine learning.

$5M – $25M

OUP (Osage University Partners)

OUP (Osage University Partners) is a venture capital firm that backs startups spinning out of leading research labs and universities, partnering with founders, researchers, and academic institutions.

$1M – $20M

Olive Tree Capital

Olive Tree Capital invests in technology and life sciences companies, backing entrepreneurs across healthcare, fintech, enterprise, AI/ML, and frontier technology sectors.

Qbic Fund

Qbic is an inter-university venture capital fund that turns technological breakthroughs from its partner universities, research institutes and hospitals into sustainable businesses.